Nakamura Ikuo
Ikuo Nakamura, Department of Gastroenterology, Tokyo Medical University, Tokyo 160-0023, Japan.
World J Gastroenterol. 2014 Jun 21;20(23):7298-305. doi: 10.3748/wjg.v20.i23.7298.
It has been reported that host defense responses, such as phagocytic function of neutrophils and natural killer (NK) cell activity of lymphocytes, are impaired in cirrhotic patients. This review will concentrate on the impairment of innate immune responses in decompensated cirrhotic patients and the effect of the treatment by branched-chain amino acids (BCAA) on innate immune responses. We already reported that phagocytic function of neutrophils was significantly improved by 3-mo BCAA supplementation. In addition, the changes of NK activity were also significant at 3 mo of supplementation compared with before supplementation. Also, Fisher's ratios were reported to be significantly increased at 3 mo of BCAA supplementation compared with those before oral supplementation. Therefore, administration of BCAA could reduce the risk of bacterial and viral infection in patients with decompensated cirrhosis by restoring impaired innate immune responses of the host. In addition, it was also revealed that BCAA oral supplementation could reduce the risk of development of hepatocellular carcinoma in cirrhotic patients. The mechanisms of the effects will also be discussed in this review article.
据报道,肝硬化患者的宿主防御反应会受损,如中性粒细胞的吞噬功能和淋巴细胞的自然杀伤(NK)细胞活性。本综述将聚焦于失代偿期肝硬化患者先天免疫反应的损害以及支链氨基酸(BCAA)治疗对先天免疫反应的影响。我们已经报道,补充3个月的BCAA可显著改善中性粒细胞的吞噬功能。此外,与补充前相比,补充3个月时NK活性的变化也很显著。而且,据报道,与口服补充前相比,补充BCAA 3个月时费希尔比率显著升高。因此,给予BCAA可通过恢复宿主受损的先天免疫反应来降低失代偿期肝硬化患者发生细菌和病毒感染的风险。此外,还发现口服补充BCAA可降低肝硬化患者发生肝细胞癌的风险。本文还将讨论这些作用的机制。